Cannabinoids for obstructive sleep apnea: A systematic review.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 880, doi. 10.1002/phar.4622
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 11
Results: 7
1
2
Update and narrative review of avian influenza (H5N1) infection in adult patients.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 870, doi. 10.1002/phar.4621
- By:
- Publication type:
- Article
3
ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 841, doi. 10.1002/phar.4620
- By:
- Publication type:
- Article
4
Sex differences in LDL‐C reduction response to evolocumab: A propensity score matching analysis.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 861, doi. 10.1002/phar.4619
- By:
- Publication type:
- Article
5
Association between gastroprotective agents and acute kidney injury in patients receiving non‐steroidal anti‐inflammatory drugs: Analysis of a Japanese hospital‐based database.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 851, doi. 10.1002/phar.4617
- By:
- Publication type:
- Article
6
Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 828, doi. 10.1002/phar.4615
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 11, p. 825, doi. 10.1002/phar.2700
- Publication type:
- Article